幽门螺杆菌重组蛋白脂质体疫苗免疫保护作用的动物实验研究
DOI:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

基金项目:

国家自然科学基金资助项目(30270078)


Experimental Study of Immune Protective Effecacy of The Liposomes-encapsulated Recombinant H. pylori Vaccine
Author:
Affiliation:

Fund Project:

This work was supported by a grant from The National Natural Science Foundation of China (30270078)

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    探讨幽门螺杆菌重组蛋白脂质体疫苗的免疫预防作用及可能的免疫机制. 用逆向蒸发法制备以卵磷脂和胆固醇为膜组分包裹的重组蛋白和/无免疫佐剂的口服疫苗,并用透射电镜测定其粒径. BALB/c小鼠分为6组,分别通过灌胃方法给予PBS、空白脂质体、UreB重组蛋白+CT、 脂质体包裹UreB重组蛋白、脂质体包裹UreB重组蛋白和CT、脂质体包裹(UreB+Kat+CT),每周1次共4次,末次攻击2周再用活幽门螺杆菌(Hp)攻击3次,5周后处死小鼠,行胃组织快速尿素酶试验、Hp的定植半定量、炎症程度及其炎症活动度的评分. RT-PCR检测小鼠脾淋巴细胞中γ-干扰素 (INF-γ) 和白细胞介素-4 (IL-4)表达. 脂质体疫苗电镜下负染,显示粒径为 (0.7±0.2) μm. PBS组、空白脂质体组、UreB重组蛋白+CT组、脂质体包裹UreB重组蛋白组、脂质体包裹UreB重组蛋白和CT组、脂质体包裹 (UreB+Kat+CT) 组的免疫保护率分别为0(0/11)、 0(0/11)、58.3%(7/12)、54.5%(6/11)、63.6%(7/11)、75.0%(9/12),UreB重组蛋白+ CT组免疫保护率与脂质体包裹UreB重组蛋白组比较无显著性差异 (P>0.05),脂质体包裹UreB重组蛋白+CT组免疫保护率与脂质体包裹 (UreB+Kat+CT) 组比较有显著性差异 (P<0.05). 各疫苗组Hp定植评分均明显低于PBS和脂质体对照组 (P<0.01),且UreB+Kat双价疫苗组较三个单价疫苗组比较也有显著性差异 (P<0.05). 疫苗组不仅能降低Hp的定植,而且能减轻Hp造成的小鼠胃黏膜的局部慢性炎症反应 (P<0.05),但各疫苗组间比较未见显著性差异(P>0.05). Hp攻击后,与对照组比较,各疫苗组脾淋巴细胞INF-γ mRNA水平较低 (P<0.05),而IL-4 mRNA水平则较高 (P<0.05),各疫苗组间比较未见显著性差异(P>0.05). 研究表明,在小鼠Hp感染模型中脂质体能部分代替霍乱毒素的免疫佐剂作用,在Hp攻击后,未经免疫小鼠体内诱导以Th1为主应答,免疫小鼠体内则诱导以Th2为主的免疫应答.

    Abstract:

    In order to investigate the immune protective efficacy and immune protective mechanism of the lipsome-encapsulated Helicobacter pylori (Hp) recombinant protein vaccines, the oral lipsome-encapsulated vaccines with/without CT were used. Phosphatidyl choline (PC) and cholesterols (Chol) were prepared using reverse evaporation method whose size distribution of folate liposomes was measured by electronic microscopy. BALB/c mice were divided into six groups and immunized by BPS alone, liposome alone, rUreB plus CT, liposome-encapsulated rUreB, liposome-encapsulated rUreB plus CT and liposome-encapsulated (rUreB and rKat) plus CT orally respectively once a week for four weeks. All mice were challenged by alive Hp three times in two weeks after the last immunization and sacrificed in five weeks after the last challenge. Hp was determined by the fast urease test. The bactrerial colonizing density semi-quantitation, the inflammation severity grades and activity grades of the gastric histopathology were observed. IFN-γ and IL-4 mRNA expression of spleen T lymphocyte cell in different groups were studied with RT-PCR. The lipsome-encapsulated vaccines were obtained successfully. The mean size of folate liposome was (0.7±0.2) μm. Protective rates of BPS alone, liposome alone, rUreB plus CT, liposome-encapsulated rUreB, liposome-encapsulated rUreB plus CT and liposome-encapsulated (rUreB and rKat) plus CT were 0(0/11), 0(0/11), 58.3%(7/12), 54.5%(6/11), 63.6%(7/11) and 75.0%(9/12) respectively. Protective rate of rUreB plus CT was equal that of the liposome-encapsulated rUreB group (P>0.05). Protective rate of liposome-encapsulated (rUreB and rKat) plus CT was significantly higher than that of liposome-encapsulated rUreB plus CT (P<0.05). The mice gastrically inoculated with the latter four immune antigens had been significantly less infected by Hp and had mild inflammation of gastric tissue (P<0.05). There was not significant difference among any vaccine group (P>0.05). After Hp attacked, the level of INF-γ mRNA expression of every vaccine group was significantly lower than that of the PBS and liposome group (P<0.05) while the level of IL-4 mRNA expression of every vaccine group was significant higher than that of the PBS and liposome group (P<0.05). There was not significant difference among any vaccine group (P>0.05). The lipsome-encapsulated vaccines can significantly decrease Hp coloning density and reduce inflammation degree in mouse model. The double- candidate vaccines have more stronger immune protective function against Hp than that of sigle-candidate vaccines. After Hp attack, the mice which infected without vaccine induce a predominant Th1 immune inflammatin response while the mice which have accepted vaccine can induce a predominant Th2 protective immune response.

    参考文献
    相似文献
    引证文献
引用本文

黄文,李兆申,白 杨,王继德,张亚历,周殿元.幽门螺杆菌重组蛋白脂质体疫苗免疫保护作用的动物实验研究[J].生物化学与生物物理进展,2006,33(10):978-985

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2006-03-21
  • 最后修改日期:2006-09-04
  • 接受日期:
  • 在线发布日期: 2006-10-18
  • 出版日期: